On December 30, 2025, Oramed Pharmaceuticals Inc. reported the successful repurchase of warrants for an aggregate payment of $14,000,000, completing a total Warrant Repurchase of $28,500,000 with Scilex Holding Company. This included earlier payments and warrants to purchase 6,500,000 shares of Scilex's common stock at $0.01 each.